Early research (Phase 1)Ended earlyNCT01832974What this trial is testingPossible New Therapy for Advanced CancerWho this might be right forAdrenocortical Carcinoma INSYS Therapeutics Inc 9
Early research (Phase 1)Study completedNCT01772004What this trial is testingAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)Who this might be right forSolid Tumors EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)Looking for participantsNCT06333314What this trial is testingDostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSIWho this might be right forPancreatic AdenocarcinomaAmpulla of Vater CarcinomaAdrenocortical Carcinoma+5 more UNICANCER 120
Testing effectiveness (Phase 2)Study completedNCT01514526What this trial is testingClinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma Spanish Oncology Genito-Urinary Group 17
Testing effectiveness (Phase 2)Looking for participantsNCT06006013What this trial is testingCabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical CancerWho this might be right forLocally Advanced Adrenal Cortex CarcinomaAdrenal Cortical CarcinomaStage III Adrenal Cortex Carcinoma+2 more Emory University 21
Large-scale testing (Phase 3)Study completedNCT00924989What this trial is testingOSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma Astellas Pharma Inc 139
Testing effectiveness (Phase 2)Looking for participantsNCT06900595What this trial is testingTesting the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical CancerWho this might be right forLocally Advanced Adrenal Cortical CarcinomaMetastatic Adrenal Cortical CarcinomaRecurrent Adrenal Cortical Carcinoma+3 more National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT03370718What this trial is testingCabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical CarcinomaWho this might be right forMetastatic Carcinoma in the Adrenal CortexStage III Adrenal Cortex Carcinoma AJCC v8Stage IV Adrenal Cortex Carcinoma AJCC v8+1 more M.D. Anderson Cancer Center 18
Early research (Phase 1)Ended earlyNCT03746431What this trial is testing[225Ac]-FPI-1434 InjectionWho this might be right forAdvanced Solid TumoursEndometrial CancerCervical Cancer+7 more Fusion Pharmaceuticals Inc. 78
Large-scale testing (Phase 3)Study completedNCT00094497What this trial is testingTrial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)Who this might be right forCarcinoma, Adrenal Cortical Collaborative Group for Adrenocortical Carcinoma Treatment 304
Testing effectiveness (Phase 2)Ended earlyNCT04187404What this trial is testingA Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/ParagangliomaWho this might be right forAdrenocortical CarcinomaPheochromocytomaParaganglioma Enterome 70